SciBite is a leading provider of semantic solutions for the life sciences and pharmaceutical industries. Headquartered in the UK

SciBite, a firm whose technology is revolutionising R&D for pharmaceutical companies across the globe.

It has acquired Cambridge based FactBio.

FactBio builds ontologies and tools for the curation and management of scientific data. The company's focus is on biomedical data, with the potential to apply its tools and techniques more widely.

FactBio will become a wholly owned subsidiary of SciBite and all business will relocate to SciBite's offices at the Wellcome Trust Genome Campus, Cambridge, UK.    

The era of data-driven R&D is motivating investment in technologies such as machine learning, artificial intelligence, data integration and natural language processing to provide deeper insights into new drug development strategies.

Through its knowledge management platform, Kusp, FactBio provides the tools to streamline this process and generate the high quality data needed for meaningful analysis.

"FactBio's platforms address a critical step in the data analysis pipeline, a growing issue for our customers. The technology shares SciBite's principles of using strong semantic data representation through high quality ontologies and together provide a holistic solution to today's big data challenges," said Rob Greenwood, CEO of SciBite. 

"Being part of SciBite will mean FactBio and its technology can fulfil its potential to meet the data needs of its life science customers as part of a much broader platform strategy," said James Malone, CEO of FactBio.

According to him it’s a great fit for both companies and they are very excited about the future.